Bone mineral density in adult Coeliac disease: An updated review

Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva (Impact Factor: 1.41). 05/2013; 105(3):154-162. DOI: 10.4321/S1130-01082013000300006
Source: PubMed


Introduction and objectives:
coeliac disease (CD) affects around 1-2 % of the world population. Most patients are now diagnosed when adults, suffering the consequences of an impaired bone mineralization. This review aims to provide an updated discussion on the relationship between low bone mineral density (BMD), osteopenia and osteoporosis, and CD.

a PubMed search restricted to the last 15 years was conducted. Sources cited in the results were also reviewed to identify potential sources of information.

low BMD affects up to 75 % of celiac patients, and can be found at any age, independently of positive serological markers and presence of digestive symptoms. The prevalence of CD among osteoporotic patients is also significantly increased. Two theories try to explain this origin of low BMD: Micronutrients malabsorption (including calcium and vitamin D) determined by villous atrophy has been related to secondary hyperparathyroidism and incapacity to achieve the potential bone mass peak; chronic inflammation was also related with RANKL secretion, osteoclasts activation and increased bone resorption. As a consequence, celiac patients have a risk for bone fractures that exceed 40 % that of matched non-affected population. Treatment of low BMD in CD comprises gluten-free diet, calcium and vitamin D supplementation, and biphosphonates, although its effects on CD have not been specifically assessed.

up to 75 % of celiac patients and 40 % of that diagnosed in adulthood present a low BMD and a variable increase in the risk of bone fractures. Epidemiological changes in CD make bone density scans more relevant for adult coeliacs.

Download full-text


Available from: Alfredo J Lucendo
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Some malabsorptive chronic diseases can influence dietary calcium intake with longterm consequences for bone tissue health. Materials and Methods: Calcium intake was evaluated using a weekly frequency questionnaire in 51 patients with celiac disease, 30 patients with cystic fibrosis, 41 patients with food allergies and 9 patients with lactose intolerance. Results: Patients with cystic fibrosis had an adequate daily calcium intake (1214±367 mg/day), whilst patients with celiac disease (769±281 mg/day), lactose intolerance (725±308 mg/day) and food allergies (884±304 mg/day) had a daily calcium intake below the recommended intake. In patients with celiac disease calcium sources were represented above all (33.1%) by drinking water, while in patients with cystic fibrosis (26.7%), food allergies (32.8%) and lactose intolerance (37.3%) the main source was dairy products. Processed foods accounted for 2.4% to 10.4% of the calcium in the diet. Conclusions: Only patients affected by cystic fibrosis, who are regularly followed by trained dieticians, took an adequate amount of calcium. This observation suggests there is a role for regular dietary advice in chronic diseases, which can positively affect food intake and nutritional status.
    No preview · Article · Jan 2014 · Nutritional Therapy and Metabolism
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With better care and intensive insulin therapy, microvascular complications have reduced and longevity has increased in patients with type 1 diabetes (T1DM). Therefore, there is a need to change the focus from microvascular complications to cardiovascular disease and osteoporosis. Though number of studies from other parts of the world show that patients with T1DM are at increased risk of osteoporosis and fractures, there is a paucity of data from India. A number of factors and mechanisms affecting bone health in patients with T1DM have been proposed. The main defect in genesis of osteoporosis is osteoblastic function, rather than osteoclastic overfunction. Assessment of bone mineral density by dual X-ray absorptiometry and other risk factors for osteoporosis, as a part of diagnostic procedure can help to design tailored treatment plans. A physically active healthy lifestyle, prevention of diabetic complications and adequate calcium and vitamin D supplementation are the mainstay for prevention of osteoporosis. Treatment of osteoporosis is not evidence based but it is proposed to be similar to osteoporosis associated with other conditions. Bisphosphonates are the mainstay for treatment of osteoporosis in patients with T1DM. However, more studies are needed to make definitive guidelines on prevention and treatment of osteoporosis in patients with T1DM.
    Full-text · Article · Mar 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with celiac disease (CD) have low bone mineral density. Evidence of increased fracture risk in these patients is conflicting, and the indication for bone mineral density screening of all adult CD patients is debated. Our aim was to review current published data on fractures in CD. Cross-sectional cohort studies and one case study were identified by searching Medline and Embase. Although the identified studies are heterogeneous and difficult to compare, the overall findings indicate a positive association between CD and risk of fracture. Adult patients with CD should be considered for bone densitometry in order to estimate fracture risk.
    Full-text · Article · Apr 2014 · Osteoporosis International
Show more